These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 2146214

  • 1. CD45 molecule cross-linking inhibits natural killer cell-mediated lysis independently of lytic triggering.
    Starling GC, Hart DN.
    Immunology; 1990 Oct; 71(2):190-5. PubMed ID: 2146214
    [Abstract] [Full Text] [Related]

  • 2. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
    Poggi A, Pella N, Morelli L, Spada F, Revello V, Sivori S, Augugliaro R, Moretta L, Moretta A.
    Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198
    [Abstract] [Full Text] [Related]

  • 3. CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules.
    Poggi A, Pardi R, Pella N, Morelli L, Sivori S, Vitale M, Revello V, Moretta A, Moretta L.
    Eur J Immunol; 1993 Oct; 23(10):2454-63. PubMed ID: 8405045
    [Abstract] [Full Text] [Related]

  • 4. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 5. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Izquierdo M, López-Botet M.
    J Immunol; 1991 Jul 15; 147(2):714-21. PubMed ID: 1830071
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen.
    Starling GC, Davidson SE, McKenzie JL, Hart DN.
    Immunology; 1987 Jul 15; 61(3):351-6. PubMed ID: 2440797
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
    Starling GC, Davidson SE, Nimmo JC, Beard ME, Hart DN.
    Clin Exp Immunol; 1989 Dec 15; 78(3):396-401. PubMed ID: 2532991
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
    Morelli L, Lemieux S.
    J Immunol; 1993 Dec 15; 151(12):6783-93. PubMed ID: 8258690
    [Abstract] [Full Text] [Related]

  • 11. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ, Bolhuis RL, Stoter G, Roozemond RC.
    J Immunol; 1987 May 15; 138(10):3137-44. PubMed ID: 2952709
    [Abstract] [Full Text] [Related]

  • 12. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME, Kim YB.
    J Immunol; 1990 Jun 01; 144(11):4452-62. PubMed ID: 1971298
    [Abstract] [Full Text] [Related]

  • 13. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T, Uciechowski P, Tetteroo PA, Kurrle R, Deicher H, Schmidt RE.
    J Immunol; 1989 Feb 15; 142(4):1102-6. PubMed ID: 2464637
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A killer cell protective antigen expressed by MHC-unrestricted killer hybridomas.
    Kubota K.
    Cell Immunol; 1997 Oct 10; 181(1):50-8. PubMed ID: 9344496
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.